Your Health Plan:
Your Health Plan:
Not SelectedBRIUMVI (ublituximab) is a biologic prescription drug for treatment of Multiple Sclerosis and Clinically isolated syndrome. BRIUMVI is a cd20-directed cytolytic antibody. It is available in the form of intravenous injection.
See full Prescribing Information for important safety information and clinical studies.
Cash price for 30-day supply is $8400-10200.
Patient Assistance Prorgams and Coupons are found: